{"acquisitions":[],"changes":[],"country":"GB","description":"Trimtech Therapeutics develops targeted protein degraders, branded TRIMTACs and TRIMGLUEs, that selectively remove disease-causing proteins to treat CNS and inflammatory disorders. It is built for patients with intractable disease driven by toxic protein buildup. Its programs use TRIM21, a widely expressed but underused ubiquitin ligase.","domain":"trimtechtherapeutics.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":null,"lng":null,"location":null,"multiples":[],"name":"Trimtech Therapeutics","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":31000000,"connectionsAmong":[],"currency":"USD","date":"2025-03-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"trimtechtherapeutics-com-2025-03-01-seed","source":{"fact":"round","publisher":"sifted","retrievedAt":"2026-04-29","status":"attributed","url":null},"status":"attributed","type":"seed","url":null}],"slug":"trimtechtherapeutics-com","sources":[{"fact":"round","publisher":"sifted","retrievedAt":"2026-04-29","status":"attributed","url":null},{"fact":"existence","publisher":"trimtechtherapeutics.com","retrievedAt":"2026-04-29","status":"self-reported","url":"https://trimtechtherapeutics.com"},{"fact":"description","publisher":"trimtechtherapeutics.com","retrievedAt":"2026-04-29","status":"self-reported","url":"https://trimtechtherapeutics.com"}],"stage":"seed","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["WordPress 7.0","Yoast SEO 27.6","Google Analytics","Google Tag Manager","jQuery Migrate 3.4.1","parallax.js","DoubleClick Floodlight","CookieYes","PHP","MySQL","jquery 3.7.1"],"totalRaisedUsd":31000000,"traction":[],"updatedAt":"2026-04-29","valuations":[]}